Literature DB >> 8064335

A 3D QSAR approach to the search for geometrical similarity in a series of nonpeptide angiotensin II receptor antagonists.

L Belvisi1, G Bravi, C Scolastico, A Vulpetti, A Salimbeni, R Todeschini.   

Abstract

A 3D QSAR methodology based on the combined use of conformational analysis and chemometrics was applied to perform a comparative analysis of the 3D conformational features of 13 nonpeptide angiotensin II receptor antagonists showing different levels of binding affinity. Conformational analysis by using a molecular mechanics MM2 method was carried out for each of these structures to obtain conformational minima. These minima were described by ten interatomic distances which define the relative spatial disposition of five significant atoms belonging to relevant functional groups present in all the 13 molecules. The structure-activity relationship between the interatomic distances and the biological activity was then assessed by using chemometric methods (cluster analysis, principal component analysis, classification methods). With our indirect approach based on the search for geometrical similarity it was possible, even though structural information on the receptor active site was lacking, to identify the 3D geometrical requirements for the binding affinity of nonpeptide angiotensin II receptor inhibitors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064335     DOI: 10.1007/bf00119868

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  8 in total

1.  Pharmacophore identification by molecular modeling and chemometrics: the case of HMG-CoA reductase inhibitors.

Authors:  U Cosentino; G Moro; D Pitea; S Scolastico; R Todeschini; C Scolastico
Journal:  J Comput Aided Mol Des       Date:  1992-02       Impact factor: 3.686

2.  Structure-activity relationship of Ca2+ channel blockers: a study using conformational analysis and chemometric methods.

Authors:  L Belvisi; S Brossa; A Salimbeni; C Scolastico; R Todeschini
Journal:  J Comput Aided Mol Des       Date:  1991-12       Impact factor: 3.686

3.  Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists.

Authors:  N B Mantlo; P K Chakravarty; D L Ondeyka; P K Siegl; R S Chang; V J Lotti; K A Faust; T B Chen; T W Schorn; C S Sweet
Journal:  J Med Chem       Date:  1991-09       Impact factor: 7.446

Review 4.  Peptides and central neural regulation of the circulation.

Authors:  J L Reid; P C Rubin
Journal:  Physiol Rev       Date:  1987-07       Impact factor: 37.312

5.  Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.

Authors:  D J Carini; J V Duncia; P E Aldrich; A T Chiu; A L Johnson; M E Pierce; W A Price; J B Santella; G J Wells; R R Wexler
Journal:  J Med Chem       Date:  1991-08       Impact factor: 7.446

6.  New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivatives.

Authors:  R H Bradbury; C P Allott; M Dennis; E Fisher; J S Major; B B Masek; A A Oldham; R J Pearce; N Rankine; J M Revill
Journal:  J Med Chem       Date:  1992-10-30       Impact factor: 7.446

7.  The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.

Authors:  J V Duncia; A T Chiu; D J Carini; G B Gregory; A L Johnson; W A Price; G J Wells; P C Wong; J C Calabrese; P B Timmermans
Journal:  J Med Chem       Date:  1990-05       Impact factor: 7.446

8.  Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives.

Authors:  D J Carini; J V Duncia; A L Johnson; A T Chiu; W A Price; P C Wong; P B Timmermans
Journal:  J Med Chem       Date:  1990-05       Impact factor: 7.446

  8 in total
  1 in total

1.  A 3D QSAR CoMFA study of non-peptide angiotensin II receptor antagonists.

Authors:  L Belvisi; G Bravi; G Catalano; M Mabilia; A Salimbeni; C Scolastico
Journal:  J Comput Aided Mol Des       Date:  1996-12       Impact factor: 3.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.